Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- INTT +30.6%, (very thinly traded), COGT +16.4%, ESES +12.7%, CVGI +6.7%, CDXS +5.4%, (light volume)
- ZGNX +5.2%, ABTL +5.2%, VCEL +5.2%, MYRG +5.1%, PVG +4.3%
- TEAR +4%, (also confirms plans to explore strategic alternatives), WLDN +4%, GST +3.5%
- MTN +1.7%, OCUL +1.6%, ZFGN +1.3%, ACTG +0.9%
M&A news:
- BT +3.6% (BT Group plc and OFCOM reach agreement on future governance of Openreach; to be a legally separate company within BT with its own Board)
- BP +2.1% (The UK's Evening Standard reports on market rumors that Exxon Mobil (XOM) has reached out to large BP shareholders regarding a potential acquisition)
Select financial related names showing strength:
- DB +2.7%, ING +2.5%, SAN +1.6%, CS +1.6%, BAC +1.1%, C +0.9%, LYG +0.9%
Other news:
- SPWR +7.2% (puts 100MW Chilean solar plant up for sale, according to Reuters)
- CRIS +5.5% (continued strength)
- PRKR +3.3% (completes sale of approx. 4.1 mln of its common stock at $2.46/shareg)
- SKLN +2.8% (light volume, schedules call to provide business update and discuss recent/upcoming milestones for March 15 at 4:30pm ET)
- CLF +2.2% (announces increase in maximum payment amount with respect to tender offers for certain of its unsecured notes)
- VRX +1.6% (prices notes offering)
- BCRX +1.3% (prices offering of 5,294,118 shares of its common stock at $8.50 per share)
- ACOR +1% (announces the PTAB has upheld four Ampyra patents)
Analyst comments:
- SRRA +8.4% (upgraded to Buy from Hold at SunTrust)
- INAP +5.3% (upgraded to Buy from Hold at Stifel)
- TTPH +3.6% (upgraded to Outperform from Market Perform at BMO Capital)
- VIP +3% (initiated with a Buy at ING Group)
- ASML +2.1% (upgraded to Buy from Neutral at UBS)
- HIMX +2.1% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
- ABBV +1% (added to Conviction Buy List at Goldman)
- YUM +0.8% (upgraded to Outperform from In-line at Evercore ISI)